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Interesting Developments
The BSCR has grown over the last few years from a society narrowly concerned with cardiac muscle to one encompassing all aspects of the cardiovascular science. This change has reflected and at times, I hope, anticipated changes in the same direction by the ISHR, ESC etc. The result is a Society of over 500 members with now widely divergent interests. Hopefully, our strength will continue to grow from this breadth. It is equally true, however, that productive scientific interactions emerge from personal contacts and are best encouraged by small informal gatherings. There is therefore a current of feeling that BSCR meetings have become too formal and also that it is no longer possible stage a main meeting of interest to every member. Informal meetings should not be inconsistent with the Society's new standing, however, and are expressly catered for by workshops. Perhaps it is time to encourage the formation of "Interest Groups" within the Society and suggest that these groups organise (regular) informal workshops at which more of the membership can have the possibility of contributing. It is my view that the BSCR will have failed in its aim of promoting interchange of ideas unless such a development takes place. I am equally sure that British Cardiovascular Research will fail to keep up without the multi-group efforts that such contacts will foster.
Without wishing to discourage the spontaneity or increase the burden of organising a workshop, I should remind prospective organisers of the main conditions which the BSCR attaches to the use of its good name and its contribution of £400. Prior approval must be obtained from the Committee, where a guiding principle will be the benefit of the proposed workshop the membership as a whole. Meetings must be open to all members, normally without any registration fee. Accounts must be kept and any residue returned to the Society. Finally, I should stress that sufficient time must be allowed for advertising to the membership and registration
Andrew Newby
CHAIRMAN'S COLUMN
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Society Meetings
The Spring meeting in Cardiff was very well attended and provided excellent reviews of recent developments in the endothelial world. We are very grateful to our Secretary for his hard work in organising this meeting. Future meetings are scheduled as follows: Winter 1991: 5-6 December in London, "Regulation of coronary and systemic blood flow", organisers Dr. Nicholas Flores and Professor Desmond Sheridan, Academic Cardiology Unit, St. Mary's Hospital. Spring 1992: Birmingham, "Myocardial receptors and innervation; therapeutic implications", organiser Dr. Peter Cummins, Department of Physiology, University of Birmingham. Winter 1992: London, "Cardiac Myofilaments", organiser Dr. John Kentish, Department of Pharmacology, St. Thomas' Hospital.
Travel Bursaries for PhD Students
At the last Committee meeting a proposal was warmly accepted to provide up to 20 travel grants of £50.00 for PhD students to help with their expenses in attending the 1991 Winter meeting of the Society in London. This level of sponsorship perhaps does not match up with that of other, much more wealthy societies but, given what student grants are worth these days, 1 anticipate that it will be welcomed. The aim is to encourage young researchers to attend and (cont.) to contribute to our meetings (remember that if you submit a poster it will not be published, merely printed, if you so wish, in the Bulletin). The Society must remain, as it always has, an informal forum for exchange of results and ideas, and I hope that more contributions from young researchers will give us some freshness and vitality.
The bursaries can be applied for on forms which will be issued with the Bulletin and which must be countersigned by the research supervisor. Awards will be given on a first-come, first-served basis but if the scheme is over-subscribed, preference will be given to applicants whose research is directly related to the areas covered by the meeting. Applicants need not be submitting an abstract but they must be, or must become, members of the Society.
A BHF Award for the Bulletin
The Education Committee of the British Heart Foundation have renewed their support for the Bulletin with another year's grant of £750.00. We are most grateful for their continued interest in this worthwhile publication.
The Society Seeks Charitable Status
The Liverpool office of the Charity Commission is presently considering the case of our Society and we look forward to their reply. Technically we are at the "questionnaire" stage which means that the Commission has been furnished with detailed responses to a standard set of questions and with a sheaf of documents concerning the activities of the Society. One of these is a draft constitution which involves the Chairman applying a cold towel to his head and marrying our (exceedingly brief and informal) set of rules with a model constitution for a voluntary society provided by the National Council for Voluntary Organisations. My aim has been to make the constitution as flexible and as unrestrictive as possible, while complying with the requirements necessary for safeguarding the good running of a society and the interests of the Commission. In fact most of the requirements are sensible and represent good practice, and the Committee voted to submit the draft at its last meeting. In drawing up the draft I have been greatly helped by the legal department of the NCVO and by a local barrister. The Commission looks at the submission in detail at this stage, making enquiries with the Inland Revenue and ensuring that the constitution is sound. When it is satisfied we may expect to be invited to submit a formal application. Hopefully we shall be in a position, at the AGM next December, for members to vote on accepting the new constitution. Benefits which the Society may expect from charitable status include tax relief on profits from meetings and on interest ftom our accounts, rules to ensure good practice in running the Society, and the production of an annual report and an audited statement of accounts. And maybe the minutes will be signed from now on!
An Insurance Policy
I have been concerned that in these days of increasing litigation we should define and safeguard our position in the unlikely event of our being sued. At some but not all of our meetings local insurance cover is in place if, for example, a speaker falls off the podium, breaks his leg and wonders about taking legal action for failure to provide a handrail! The result is that the Committee have approved a liability insurance policy for the Society costing approximately £100 pa and covering us to a vast sum. But libel and slander are excluded, so do please be careful what you say! With that I hope these important housekeeping matters are at an end and next time I shall be able to write about cardiovascular research... Belgium. The meeting was planned for 100, but last minute switching to a larger lecture theatre and flexibility on the part of the Residences Administration allowed us to seat and accommodate all those who applied to attend. There were 14 poster submissions, which we managed to reduce to our limit of twelve by some amicable (I hope) arm-twisting. Posters were on display throughout the meeting (abstracts reproduced on pages 10-12). The almost overwhelming response to a symposium outside the traditional area of the old Cardiac Muscle Research Group was most gratifying.
George Hart
BSCR MEETING ANNOUNCEMENT
Prof. Ross opened the meeting by giving the 5th Dame Honor B. Fell Memorial Lecture (organised jointly with the UWCM Tissue Culture and Cell Biology Club), and he acknowledged having spent formative years in Dame Honor's laboratory in Cambridge. Prof. Ross gave a pathologist's eye view of atherogenesis illustrated by quite splendid original micrographs. He laid stress on the sequence of events during atherogenesis in cholesterol fed monkeys, namely early ingress of monocytes and later generation of endothelial denudation and smooth muscle cell proliferation. He went on to describe important but differing roles for PDGF, TGFB, IGF-1 and FGF in the generation of plaques, which had been elucidated from both tissue culture and whole animal models.
The remainder of the afternoon was devoted to discussion of endothelial interactions with other vascular cells. Dr. R. F. G. Booth reviewed the mechanisms underlying monocyte adhesion to endothelium and presented data on the role of the protein kinase C pathway obtained with novel selective inhibitors. Dr. J. D. Pearson described the role of endothelial calcium and protein kinase C in regulating the production of prostacyclin, nitric oxide and von Willebrand factor all of which modulate platelet-endothelium interactions. The role of nitric oxide production from endothelium and platelets themselves was taken up by Dr. M. Radomski. Endothelial control of vascular smooth muscle cell proliferation was reviewed by Dr. A. A. Soyombo, who presented data on potentially novel proliferation enhancing activity produced by the endothelial cells in organ cultures of human saphenous vein. Dr. P. L. Weissberg completed the afternoon's programme by describing the action of endothelins to potentiate PDGF-induced vascular smooth muscle proliferation.
Wednesday morning opened with four papers related to lipoprotein interactions with endothelium. Dr. P. D. Weinberg described the localisation of transendothelial lipoprotein transport using novel fluorescence microscopy methods and related this to sites prone to atheroma formation. Prof. A. G. Herman described the influence of models of hyperlipidaemia-induced atherogenesis on the function of endothelium as measured by impaired release of nitric oxide. Dr. D. S. Leake discussed the mechanisms by which endothelium and other vascular cell can modify low density lipoproteins to increase their atherogenicity. Dr. M. Jacobs then described the dii'ect effects of normal and oxidatively modified LDLs to inhibit endothelial nitric oxide production.
The meeting was rounded off by a discussion of the importance of endothelium in clinically-encountered atherosclerosis from the cardiac surgeons point of view. In reviewing the literature and his own studies, Mr. G. D. Angelini achieved a perfect balance in conveying a serious message through the medium of a very lighthearted presentation.
Thanks are owing to Jill Allen, Gail Hughes and Wendy Simons, as well as many members of the Cardiff Cardiovascular Sciences Research Group, who bore the major burdens of organising the meeting. We are indebted to the British Heart Foundation for providing a visiting professorship to Prof Ross and to the British Cardiac Society for a lectureship to Prof Herman. The UWCM accommodated the meeting free of the usual charges. Finally, the meeting would have been impossible without the very generous financial support of Bayer (U. K.) Ltd.
Andrew Newby
READERS'VIEWS
"Power and impedance in the cardiovascular system" While not producing any firm conclusions that could be applied to the assessment of mechanical performance in small mammalian hearts, the recent workshop at Lambeth Palace was important for highlighting the polarisation of engineering and physiology principles.
In engineering, the physical properties of complex electromechanical systems are described by terms that are amenable to accurate mathematical formulations. Terms like power transfer function and load impedance are carefully defined and related by correctly dimensioned equations.
By comparison, cardiovascular physiology is a pseudo-science based upon ill-defined parameters such as 'myocardial contractility' and 'inotropic effect', and functional assessment that frequently embodies assumptions and approximations that can only be justified by generalisations. Empirical parameters, such as dP/dtmax, rate-pressure product and tension-time integral are obtuse and nebulous. They are subject to complex problems of methodology and interpretation and have weak theoretical bases. The paramount difference between systems analysis in engineering and physiology is the greater mathematical rigour and precision of the engineering techniques. Physiology protects itself from the demand for mathematical determination by the excuse of the biological diversity and variation.
Potential applications for engineering techniques in physiology are numerous. For the analysis of cardiovascular function, electrical transmission line theory provides the relevant mathematical basis. The heart is then analogous to a transducer that converts chemical energy stored in molecules of ATP into mechanical energy. With negligible losses due to the formation of heat, this energy is used to perform work. A variable proportion of this work is internal. That is, it is used to overcome the source impedance of the heart -in more familiar terms, the sliding viscoelastic resistance. The ratio of intemal to external work is a measure of myocardial efficiency.
External work results in the generation of blood flow and blood pressure in the proximal aorta and the rate of performing work is haemodynamic power. Power is a complex quantity in both conceptual and mathematical senses. The power spectrum consists of a frequency domain series of amplitude and phase relations. In this form, the external performance if the heart is comprehensively described, but the spectral data is difficult to interpret. A presentation that is easier to assimilate is to equate total haemodynamic power (W)^ to the interdependent sums of mean (W_^) and pulsatile (Wp power, potential (W ) and kinetic (W^) power, and cospectral (C^ (pressure and flow in-phase) and quadrature (D^ power (pressure and flow out-of-phase). All of these parameters are easily computed from the Fourier components of the pressure and flow signals. The subscript's' = jw (j =/^l, w = 2 jcf, f = frequency) indicates that cospectral and quadrature power are dependent upon the heart rate. Haemodynamic power completely describes the external performance of the heart under any set of input and output loading conditions. The load that the heart works against is the vascular impedance. For the left ventricle, it is the aortic input impedance. Like power, impedance is also complex and can be described by the impedance spectrum (Z^, but the total impedance are the peripheral vascular resistance (Rp), characteristic resistance (Rc), arterial compliance (C) and inductance (L). By this process, parameters that are indeterminate by standard physiological techniques are revealed and the contributions of the arteries (Rc and C), arterioles (Rp) and blood volume (L) to the vascular load are distinguished.
Thus, cardiovascular function can be described by the computation of haemodynamic power and aortic input impedance. The technique is based upon elementary mechanics and electrical transmission line theory. It is equally applicable to isolated and in situ mammalian hearts, human patients and mechanical pumps. The measurement of blood pressure and flow can be made precisely and no assumptions concerning the relationships between cardiovascular function and the computed parameters are necessary. The specific relationships are:
Haemodynamic power
Aortic input impedance W = -t-Z = sL -I-Rp 1 -I-sL/Rc 1 + sRpC
w, = w^-^w, It is extremely refreshing to open a major review text and to discover that the editors have adopted a rational approach to their subject that makes it accessible and relevant to readers from a diverse range of subspecialities. Drs. Pohost and O'Rourke are to be congratulated on the organisation of their book which is divided into three sections. The first subdivides cardiovascular imaging by modality with subsections on echocardiography, nuclear medicine, radiology and MRI. I was a littie disappointed to discover that 'state of the art imaging' is given a disproportionate amount of space relative to its current clinical role (e.g. MRI covers 98 pages and angiography 40). Each subsection begins with a lucid and (mercifully) concise chapter on basic principles followed by chapters on the application of the modality to disease states. These chapters are (quite righUy) written by imaging experts rather than jobbing clinicians. Whilst this lends a quiet authority to the imaging aspects of the text, however, there are a number of controversial references to clinical practice, such as the assertion that cardiac catheterisation is essential for the differentiation of papillary muscle rupture and ventricular septal defect following myocardial infarction. Each subsection ends with a consideration of future trends. In such a rapidly moving field no text can hope to be comprehensive, but I was again disappointed at the omission of any reference to angioscopy and the relatively short section on trans-oesophageal echocardiography. Clinical integration of the various modalities is much better covered in the second section where clinicians consider the rational use of imaging by disease process. This approach inevitably leads to some duplication and contradiction between the sections but these disadvantages are far outweighed by the benefits of clarity and ease of reference. These chapters are authoritative but not comprehensive. There is no chapter on the clinical use of imaging in aortic disease although this is adequately covered within the first section. The rational use of imaging is further considered in the third section which covers the important and often ignored issue of cost. The text is copiously illustrated and eight pages are devoted to colour plates. Photographic reproductions are of such high quality that I would defy even a non-clinician to miss their diagnostic implications. Similarly, line drawings are clear and well annotated.
The broad scope of this book and its authoritative execution commends it as a reference text to all with an interest in cardiac imaging. The separation of clinical and technical aspects makes it accessible to the basic scientist as well as the clinician. It would make a welcome occupant of the library shelves of any cardiac department.
Clive Lawson Transport of L-glutamine, a putative inhibitor of EDRF biosynthesis, was studied in cultured human venous endothelial cell monolayers. Uptake was mediated via a saturable carrier system dependent upon extracellular sodium and sensitive to inhibition by substrates for amino acid transport systems N (L-asparagine) and ASC (L-cysteine). By contrast, L-arginine (1 mM), ll-2-amino-bicyclo-(2,2.1 )heptane-2-carboxYlic acid (1 mM) and 2-methylaminoisobutyric acid (1 mM), respective substrates for amino acid transport systems y'^, L and A, were ineffective inhibitors. In kinetic experiments calculated K," and V"" values for L-glutamine transport were 0.14 mM and 2.5 pmol/min//;g protein, respectively. Basic (bPGF) and acidic (aFGF) fibroblast growth factors have been implicated in several growth processes in the heart, including myocyte proliferation and angiogenesis. The aim of this study was to establish the characteristics of the respective mRNA's, level of protein expression and cellular localisation of these factors. Total cell RNA was isolated from 20-30 v\/eek gestation bovine fetal ventricles and probed with cDNA's specific for aFGF and bFGF. Despite these mRNA's being present at low copy number and normally undetectable in the heart, bFGF mRNA was detected at 7.1Kb and aFGF at 3.8 Kb. These are compatible with mRNA sizes in other organs. ELISA of bFGF indicated levels of 380 to 520 pg/kg in the developing ventricle, considerably higher than previously determined.Immuno-cytochemical investigations using a polyclonal anti-recombinant bovine bFGF localised bFGF not only in blood vessels but also the cardiac myocytes. These results have important implications for the role of FGF's in myocyte proliferation. In addition to their well recognised anti-coagulant effects, heparin-like compounds are also reported to induce pro-fibrinolytic activity. This response may contribute to the anti-angiogenic actions reported for these compounds, and is particularly evident with heparin corticosteroid combinations. The aim of this study was to further investigate the pro-fibrinolytic action of these compounds by measuring intracellular levels of tPA and PAI-1 antigen following a 3-6 day treatment of human umbilical vein endothelial cells. Pentosan polysulphate (lOOug/ml), heparin (90ug/ml) and a heparin (90ug/ml) + hydrocortisone (lOOug/ml) combination (but not hydrocortisone alone) significantly increased intracellular levels of tPA antigen. This effect was most dramatic with the heparin steroid combination. A parallel reduction in intracellular levels of PAI-1 was also observed. If mirrored in vivo. this response would lead to increased plasma fibrinolytic capacity which in turn could contribute to the anti-angiogenic action of these compounds. CGRP is a 37-residue peptide and has potent vasodilating effect on CA. A correlation between decreasing vessel diameter and increasing vas9dilative response to CGRP in pig heart was reported. In the preseilt study, specific binding sites for huioan ^lpha-(;GRP m porcine CA wefe localized and characterized using quantitative autpradiograpfiy.
EXPRESSION OF FIBROBLAST GROWTH FACTOR
BALLOON CATHETER DE-ENDOTIIELIALISATION OF THE NUDE RAT CAROTID
THE USE OF L-ARGININE HYDROCHLORIDE AS AN ACUTE HYPOTENSIVE AGENT
Fresh porcine hearts (n=5) were obtained fron a local slaughter house and snap frozen. Tissue sections (10 ua thicl() froB ventricles were cut on a cryostat and thaw-mounted onto gelatin-coated slides. Receptor autoradiography was carried out as described previously. Tissue sections were incubated in the presence of 0.34 nH [1251] alpha-fiCGRP (AmershaD, UK) ?t 4 C for 2 hr, Hon-specifi9 binding was defined by coincubating an adjacent section with 1 uK alpha-hCGRP. A displaceiaent experiiient was carried.out with 0.1 nH to 1 uH alpha-or beta-RCGRP in the presence of 0.2 nH [1251 alpha-hCGEP. CGi fP bindina was guantified in autoradiograas using a computer-assisted iiaqe analysis system by com] ano laris on with a series of redioactive tissue paste standards. The average density of binding was expressed as /sq m. TRe bindinq to CGRP receptor in the CA was time-dependent and saturable. Specific bindinq was higher to SCA [internal diameter (ID) < 1 mm, 61 amol/sq Bin] than to larqe a (La 1.5 mm < ID < 5.5 mm, 28 amol/sq mm, p < 0.0001, unpaired two tailed student's t test). Host of the bindinq in LCA appeared to be associated with the intiia and media. In one experiment, similar displacement curves with alpha-or beta-hCGRP were obtained in both LCA and SCA. alpha-hCGRP showed less affinity (IC50 2.3 nH) than beta-hCGRP (IC50 1.3 nH) m both LCA and sa. The Bmax for CGRP receptor in the LCA was 114 fmol/mq protein, whereas the Bmax in the SCA was 255 fmol/mg protein.
. Our results haye demonstrated a higher density of specific ^)indinq sites for CGRP existed in small porcine CA, which is consistent with previous phafmacoloqical studies. CGRP miqht play a more important role in the regulation of blood supply to the myocites throuqh its receptor m the small CA.
